Prognostic significance of preoperative neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with gallbladder carcinoma

详细信息    查看全文

• 作者：Y. Zhang ; C. Jiang ; J. Li ; J. Sun ; X. Qu
• 关键词：Neutrophil/lymphocyte ratio ; Platelet/lymphocyte ratio ; Prognosis ; Five ; year survival rate ; Gallbladder cancer
• 刊名：Clinical and Translational Oncology
• 出版年：2015
• 出版时间：October 2015
• 年：2015
• 卷：17
• 期：10
• 页码：810-818
• 全文大小：1,004 KB
• 参考文献：1.Liu Y, He X, Wang J, Li J, Li K, Liu F et al. Establishment of liver metastasis model of human gallbladder cancer and isolation of the subpopulation with high metastatic potential. Zhonghua yi xue za zhi. 2006;86:2117鈥?1.PubMed
  2.Butte JM, Matsuo K, G枚nen M, D'Angelica MI, Waugh E, Allen PJ et al. Gallbladder cancer: differences in presentation, surgical treatment, and survival in patients treated at centers in three countries. J Am Coll Surg. 2011;212:50鈥?1.CrossRef PubMed
  3.Haq N, Khan BA, Imran M, Akram A, Jamal AB, Bangash F. Frequency of gall bladder carcinoma in patients with acute and chronic cholecystitis. J Ayub Med Coll Abbottabad. 2014;26:191.PubMed
  4.Miller G, Jarnagin W. Gallbladder carcinoma. Eur J Surg Oncol (EJSO). 2008;34:306鈥?2.CrossRef
  5.Bartlett DL, Fong Y, Fortner JG, Brennan MF, Blumgart LH. Long-term results after resection for gallbladder cancer. Implications for staging and management. Ann Surg. 1996;224:639.PubMed Central CrossRef PubMed
  6.Wu XS, Shi LB, Li ML, Ding Q, Weng H, Wu WG, Cao Y, et al. Evaluation of two inflammation-based prognostic scores in patients with resectable gallbladder carcinoma. Ann Surg Oncol. 2014;21:449鈥?7.CrossRef PubMed
  7.Kinoshita A, Onoda H, Imai N, Iwaku A, Oishi M, Tanaka K et al. The Glasgow Prognostic Score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma. BMC cancer. 2013;13:52.PubMed Central CrossRef PubMed
  8.Azab B, Bhatt VR, Phookan J, Murukutla S, Kohn N, Terjanian T et al. Usefulness of the neutrophil-to-lymphocyte ratio in predicting short-and long-term mortality in breast cancer patients. Ann Surg Oncol. 2012;19:217鈥?4.CrossRef PubMed
  9.Duan H, Zhang X, Wang F-X, Cai M-Y, Ma G-W, Yang H et al. Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma. World J Gastroenterol. 2015;21:5591.PubMed Central CrossRef PubMed
  10.Gao F, Li X, Geng M, Ye X, Liu H, Liu Y et al. Pretreatment neutrophil-lymphocyte ratio: an independent predictor of survival in patients with hepatocellular carcinoma. Medicine. 2015;94:e639.CrossRef PubMed
  11.Fan W, Zhang Y, Wang Y, Yao X, Yang J, Li J. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of survival and metastasis for recurrent hepatocellular carcinoma after transarterial chemoembolization. PLoS One. 2015;10.
  12.Nevin JE, Moran TJ, Kay S, King R. Carcinoma of the gallbladder. Staging, treatment, and prognosis. Cancer. 1976;37:141鈥?.CrossRef PubMed
  13.Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncology. 2010;17:1471鈥?.CrossRef PubMed
  14.Gregory AD, Houghton AM. Tumor-associated neutrophils: new targets for cancer therapy. Cancer Res. 2011;71:2411鈥?.CrossRef PubMed
  15.Demers M, Krause DS, Schatzberg D, Martinod K, Voorhees JR, Fuchs TA, et al. Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis. Proc Natl Acad Sci. 2012;109:13076鈥?1.PubMed Central CrossRef PubMed
  16.Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Immunity. 2004;21:137鈥?8.CrossRef PubMed
  17.Fogar P, Sperti C, Basso D, Sanzari MC, Greco E, Davoli C, et al. Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome. Pancreas. 2006;32:22鈥?.CrossRef PubMed
  18.Adamek M, Kawczyk-Krupka A, Mostowy A, Czuba Z, Krol W, Kasperczyk S, Jakobisiak M, et al. Topical ALA-PDT modifies neutrophils鈥?chemiluminescence, lymphocytes鈥?interleukin-1beta secretion and serum level of transforming growth factor beta1 in patients with nonmelanoma skin malignancies: a clinical study. Photodiagnosis Photodyn Ther. 2005;2:65鈥?2.CrossRef PubMed
  19.Templeton AJ, McNamara MG, 艩eruga B, Vera-Badillo FE, Aneja P, Oca帽a A et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106:dju124.
  20.Gay LJ, Felding-Habermann B. Contribution of platelets to tumour metastasis. Nat Rev Cancer. 2011;11:123鈥?4.CrossRef PubMed
  21.Takagi S, Sato S, Oh-hara T, Takami M, Koike S, Mishima Y, et al. Platelets promote tumor growth and metastasis via direct interaction between Aggrus/podoplanin and CLEC-2. PLoS One. 2013;8:e73609.PubMed Central CrossRef PubMed
  22.Cho MS, Bottsford-Miller J, Vasquez HG, Stone R, Zand B, Kroll MH, et al. Platelets increase the proliferation of ovarian cancer cells. Blood. 2012;120:4869鈥?2.PubMed Central CrossRef PubMed
  23.Asher V, Lee J, Innamaa A, Bali A. Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer. Clin Transl Oncol. 2011;13:499鈥?03.CrossRef PubMed
  24.Templeton AJ, Ace O, McNamara MG, Al-Mubarak M, Vera-Badillo FE, Hermanns T et al. Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis. Cancer Epidemiol Biomark Prev. 2014 (cebp. 0146).
  25.Roxburgh CS, McMillan DC. Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol. 2010;6:149鈥?3.CrossRef PubMed
  26.Koike Y, Miki C, Okugawa Y, Yokoe T, Toiyama Y, Tanaka K, et al. Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer. J Surg Oncol. 2008;98:540鈥?.CrossRef PubMed
  27.Jagdev S, Gregory W, Vasudev N, Harnden P, Sim S, Thompson D, et al. Improving the accuracy of pre-operative survival prediction in renal cell carcinoma with C-reactive protein. Br J Cancer. 2010;103:1649鈥?6.PubMed Central CrossRef PubMed
  28.Yokoyama Y, Ebata T, Igami T, Sugawara G, Ando M, Nagino M. Predictive power of prothrombin time and serum total bilirubin for postoperative mortality after major hepatectomy with extrahepatic bile duct resection. Surgery. 2014;155:504鈥?1.CrossRef PubMed
  29.Nomura S, Watanabe M, Komine O, Shioya T, Toyoda T, Bou H, et al. Serum total bilirubin elevation is a predictor of the clinicopathological severity of acute appendicitis. Surg Today. 2014;44:1104鈥?.CrossRef PubMed
  
• 作者单位：Y. Zhang (1) (2)
  C. Jiang (2)
  J. Li (3)
  J. Sun (1)
  X. Qu (1)
  
  1. Institute of Basic Medical Sciences, Qilu Hospital, Shandong University, No. 107, Wen Hua Xi Road, Jinan, 250012, Shandong, People鈥檚 Republic of China
  2. Department of Pathology, Qingdao Municipal Hospital, School of Medicine, Qingdao University, Qingdao, 266011, Shandong, China
  3. Central Laboratory, Qingdao Municipal Hospital, School of Medicine, Qingdao University, Qingdao, 266011, Shandong, China
  
• 刊物主题：Oncology;
• 出版者：Springer Milan
• ISSN：1699-3055

文摘

Purpose Neutrophil/lymphocyte ratio (NLR) and platelet/lymphocyte ratio (PLR) were immune response-related indicators. Preoperative NLR and PLR had been considered to be related to the prognosis of various cancers. The objective of this study was to evaluate the prognostic significance of NLR and PLR in patients with gallbladder carcinoma (GBC).